Klaas Financial Asset Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-213
Closed -$35K 61
2022
Q3
$35K Hold
213
0.01% 56
2022
Q2
$38K Hold
213
0.01% 55
2022
Q1
$38K Sell
213
-40
-16% -$6.81K 0.01% 55
2021
Q4
$43K Buy
253
+41
+19% +$6.71K 0.01% 53
2021
Q3
$34K Buy
212
+1
+0.5% +$171 0.01% 57
2021
Q2
$35K Buy
211
+2
+1% +$331 0.01% 57
2021
Q1
$34K Sell
209
-18
-8% -$2.91K 0.01% 50
2020
Q4
$36K Buy
+227
New +$33.5K 0.01% 44

Other funds holding JNJ

Klaas Financial Asset Advisors's JNJ Position: Q4 2022 in Review

Klaas Financial Asset Advisors sold out of Johnson & Johnson (JNJ) in Q4 2022, closing a stake of 213 shares — an estimated $35K sold.

Klaas Financial Asset Advisors first reported a position in JNJ in Q4 2020 and held it in 8 quarters. The position peaked at $43K in Q4 2021. 3,789 funds tracked by Wall St. Rank hold JNJ as of Q4 2022.

  • Klaas Financial Asset Advisors reported no remaining Johnson & Johnson position as of Q4 2022 after selling out during the quarter.
  • Klaas Financial Asset Advisors sold 213 Johnson & Johnson shares in Q4 2022, an estimated $35K.
  • Klaas Financial Asset Advisors first reported a position in Johnson & Johnson in Q4 2020 and held it in 8 quarters.
  • Klaas Financial Asset Advisors's Johnson & Johnson position peaked at $43K in Q4 2021.
  • 3,789 funds tracked by Wall St. Rank held Johnson & Johnson as of Q4 2022.

Based on Klaas Financial Asset Advisors's 13F filing for Q4 2022, filed 23 Jan 2023.